The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Live Cell Imaging Market, along with revenue estimates & forecasts and market share analysis.
Growth in the live cell imaging market can primarily be attributed to various factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research.
Live Cell Imaging Market segmentation:
The Major Players Opearting in the Live Cell Imaging Market:
Key players in the Live Cell Imaging Market include Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea).
Danaher was the leading player in the global Live Cell Imaging Market. The company has a strong presence in North America, Europe, Asia, and Latin America.
The company focuses on improving its R&D capabilities to unlock additional synergies and growth opportunities. Its innovative capabilities are evident from the products the company has launched in recent years, such as the SP8 FALCON launched in March 2018, which is an integrated contrast microscope that enables researchers to monitor interactions between proteins in living cells. R&D is a key area of focus for Danaher—it invested USD 1.13 billion in R&D activities in 2017.
Geographical Detailed Analysis for Live Cell Imaging Market:
North America is the largest regional segment in the Live Cell Imaging Market followed by Europe, Asia, and the Rest of the World (Row).
The live cell imaging market in the region is driven by the availability of government funding for life science research, drug development regulations, advances in live cell imaging techniques, growth in the biotechnology and pharmaceutical industries, and the rising incidence of cancer.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly